| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Medicine, Division of Rheumatology, Mayo Clinic and Foundation, Rochester, Minnesota
Inflammation of the arterial wall in giant cell arteritis induces a
series of structural changes, including the formation of new
vasa vasorum. To study the regulation of neoangiogenesis in giant cell
arteritis, temporal arteries were examined for the extent and
localization of microvessel generation and for the production of
angiogenic factors. In normal arteries, vasa vasorum were
restricted to the adventitia, but in inflamed arteries,
capillaries emerged in the media and the intima. These capillaries
displayed a distinct topography with a circumferential arrangement in
the external one-third of the intima. Neovascularization was closely
correlated with the formation of lumen-obstructing intima, the
fragmentation of the internal elastic lamina, and the presence
of multinucleated giant cells. Comparison of tissue cytokine
transcription in temporal arteries of giant cell arteritis patients
with and without up-regulated neoangiogenesis identified interferon-
and vascular endothelial growth factor but not fibroblast growth
factor-2 as mediators associated with vasa vasorum proliferation. Giant
cells and CD68-positive macrophages at the media-intima junction were
found to be the major cellular sources of vascular endothelial growth
factor. These data demonstrate that formation of new vasa vasorum in
vasculitis is regulated by inflammatory cells and not by arterial wall
cells, raising the possibility that it represents a primary
disease mechanism and not a secondary hypoxia-induced event. Increased
neovascularization in interferon-
-rich arteries suggests that the
formation of new vasa vasorum is determined by the nature of the immune
response in the arterial wall, possibly resulting from the
generation and functional activity of multinucleated giant
cells.
This article has been cited by other articles:
![]() |
F. Tato and U. Hoffmann Giant cell arteritis: a systemic vascular disease Vascular Medicine, May 1, 2008; 13(2): 127 - 140. [Abstract] [PDF] |
||||
![]() |
D. Makkuni, A. Bharadwaj, K. Wolfe, S. Payne, A. Hutchings, and B. Dasgupta Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Rheumatology, April 1, 2008; 47(4): 488 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Segarra, A. Garcia-Martinez, M. Sanchez, J. Hernandez-Rodriguez, E. Lozano, J. M Grau, and M. C Cid Gelatinase expression and proteolytic activity in giant-cell arteritis Ann Rheum Dis, November 1, 2007; 66(11): 1429 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann and A. Lerman Atherosclerosis in the Back Yard J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2102 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann, L. O. Lerman, D. Mukhopadhyay, C. Napoli, and A. Lerman Angiogenesis in Atherogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1948 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Cheema, T. Hong, N. Nili, A. Segev, J. G. Moffat, K. E. Lipson, A. R. Howlett, D. W. Holdsworth, M. J. Cole, B. Qiang, et al. Adventitial Microvessel Formation After Coronary Stenting and the Effects of SU11218, a Tyrosine Kinase Inhibitor J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mitsuyama, W. Matsuyama, J. Iwakawa, I. Higashimoto, M. Watanabe, M. Osame, and K. Arimura Increased serum vascular endothelial growth factor level in churg-strauss syndrome. Chest, February 1, 2006; 129(2): 407 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Gerasimovskaya, N. J. Davie, S. Ahmad, D. A. Tucker, C. W. White, and K. R. Stenmark Extracellular Adenosine Triphosphate: A Potential Regulator of Vasa Vasorum Neovascularization in Hypoxia-Induced Pulmonary Vascular Remodeling,* Chest, December 1, 2005; 128(6_suppl): 608S - 610S. [Full Text] [PDF] |
||||
![]() |
A. Bharadwaj, B. Dasgupta, K. Wolfe, C. Nordborg, and E. Nordborg Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis Rheumatology, December 1, 2005; 44(12): 1579 - 1580. [Full Text] [PDF] |
||||
![]() |
R. Khurana, M. Simons, J. F. Martin, and I. C. Zachary Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal Circulation, September 20, 2005; 112(12): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Pla, J. A. Bosch-Gil, J. Rossello-Urgell, P. Huguet-Redecilla, J. H. Stone, and M. Vilardell-Tarres Metalloproteinase-2 and -9 in Giant Cell Arteritis: Involvement in Vascular Remodeling Circulation, July 12, 2005; 112(2): 264 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma-Krupa, M.-S. Jeon, S. Spoerl, T. F. Tedder, J. J. Goronzy, and C. M. Weyand Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis J. Exp. Med., January 20, 2004; 199(2): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Weyand and J. J. Goronzy Giant-Cell Arteritis and Polymyalgia Rheumatica Ann Intern Med, September 16, 2003; 139(6): 505 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Weyand and J. J. Goronzy Medium- and Large-Vessel Vasculitis N. Engl. J. Med., July 10, 2003; 349(2): 160 - 169. [Full Text] [PDF] |
||||
![]() |
K. S. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, E. Sylvin, K.-M. Lo, S. Gillies, K. Javaherian, and J. Folkman Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis PNAS, April 15, 2003; 100(8): 4736 - 4741. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Krupa, M. Dewan, M.-S. Jeon, P. J. Kurtin, B. R. Younge, J. J. Goronzy, and C. M. Weyand Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis Am. J. Pathol., November 1, 2002; 161(5): 1815 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cid, J. Hernandez-Rodriguez, M.-J. Esteban, M. Cebrian, Y. S. Gho, C. Font, A. Urbano-Marquez, J. M. Grau, and H. K. Kleinman Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis Circulation, September 24, 2002; 106(13): 1664 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Borkowski, B. R. Younge, L. Szweda, B. Mock, J. Bjornsson, K. Moeller, J. J. Goronzy, and C. M. Weyand Reactive Nitrogen Intermediates in Giant Cell Arteritis : Selective Nitration of Neocapillaries Am. J. Pathol., July 1, 2002; 161(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Blain, I. Abdelmouttaleb, J. Belmin, A. Blain, J. Floquet, J.-L. Gueant, and C. Jeandel Arterial Wall Production of Cytokines in Giant Cell Arteritis: Results of a Pilot Study Using Human Temporal Artery Cultures J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2002; 57(4): M241 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann, L. O Lerman, M. Rodriguez-Porcel, D. R Holmes Jr., D. M Richardson, E. L Ritman, and A. Lerman Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia Cardiovasc Res, September 1, 2001; 51(4): 762 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nelimarkka, H. Salminen, T. Kuopio, S. Nikkari, T. Ekfors, J. Laine, L. Pelliniemi, and H. Jarvelainen Decorin Is Produced by Capillary Endothelial Cells in Inflammation-Associated Angiogenesis Am. J. Pathol., February 1, 2001; 158(2): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |